These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24648004)

  • 21. Migraine and Obesity: Is There a Relationship? A Systematic Review and Meta-Analysis of Observational Studies.
    Hatami M; Soveid N; Lesani A; Djafarian K; Shab-Bidar S
    CNS Neurol Disord Drug Targets; 2021; 20(9):863-870. PubMed ID: 34259152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sumatriptan/Naproxen Sodium: A Review in Migraine.
    Syed YY
    Drugs; 2016 Jan; 76(1):111-21. PubMed ID: 26628293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute migraine. Sumatriptan-naproxen combination tablets work better than a single substance].
    Kreutzkamp B
    Med Monatsschr Pharm; 2007 Sep; 30(9):348-9. PubMed ID: 17912879
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of sumatriptan and naproxen for migraine.
    Hill KP; Hope O
    JAMA; 2007 Sep; 298(11):1276; author reply 1276-7. PubMed ID: 17878418
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of migraine with special reference to sumatriptan].
    Baumhackl U
    Wien Med Wochenschr; 1994; 144(5-6):110-3. PubMed ID: 8053215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
    Allais G; Castagnoli Gabellari I; Rolando S; Benedetto C
    Expert Rev Neurother; 2011 Oct; 11(10):1383-7. PubMed ID: 21955195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study.
    Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R
    Cephalalgia; 2018 Apr; 38(5):904-911. PubMed ID: 28677995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine headache and bipolar disorder comorbidity: A systematic review of the literature and clinical implications.
    Leo RJ; Singh J
    Scand J Pain; 2016 Apr; 11():136-145. PubMed ID: 28850455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.
    Krymchantowski AV; Barbosa JS
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):708-11. PubMed ID: 11593269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for the acute treatment of migraine in children and adolescents.
    Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Lockwood AH
    Neurology; 2009 Apr; 72(15):1368; author reply 1368-9. PubMed ID: 19365064
    [No Abstract]   [Full Text] [Related]  

  • 35. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes.
    Landy S; DeRossett SE; Rapoport A; Rothrock J; Ames MH; McDonald SA; Burch SP
    MedGenMed; 2007 Jun; 9(2):53. PubMed ID: 17955107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies.
    Ravindran MK; Zheng Y; Timbol C; Merck SJ; Baraniuk JN
    BMC Neurol; 2011 Mar; 11():30. PubMed ID: 21375763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine.
    Fox AW
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):513-6. PubMed ID: 23121272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
    Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
    Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The link between obesity and migraine in childhood: a systematic review.
    Farello G; Ferrara P; Antenucci A; Basti C; Verrotti A
    Ital J Pediatr; 2017 Mar; 43(1):27. PubMed ID: 28270183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.